Core Laboratories (CLB) Total Non-Current Liabilities (2022 - 2026)

Core Laboratories has reported Total Non-Current Liabilities for 5 years, with the latest figure at $303.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 2.68% year-over-year to $303.0 million; the trailing twelve-month figure through Mar 2026 stood at $303.0 million (down 2.68% YoY), and the FY2025 full-year result was $302.2 million, down 3.17% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $303.0 million, roughly flat from $302.2 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $373.9 million in Q4 2022, with the low at $292.5 million in Q3 2025.
• Historically, Total Non-Current Liabilities has averaged $327.2 million across 5 years, with a median of $323.8 million in 2024.
• Annual changes were most pronounced in 2025 — Total Non-Current Liabilities declined 9.66% — and 2026, when it slipped 2.68%.
• Core Laboratories' Total Non-Current Liabilities stood at $373.9 million in 2022, then declined by 8.55% to $342.0 million in 2023, then decreased by 8.74% to $312.1 million in 2024, then slipped by 3.17% to $302.2 million in 2025, then climbed by 0.26% to $303.0 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $303.0 million (Q1 2026), $302.2 million (Q4 2025), and $292.5 million (Q3 2025), per Business Quant data.